新闻中心

Establishing a Precision Tumor Model: Launch of the A375-NRAS-Q61K-KI Cell Line

Kyinno Biotechnology 24.10.2025

了解更多 »

PD-1/VEGF Bispecific Antibody Sets Record Overseas, VEGF/VEGFR2 Reporter Cell Models Aid Target Development

Kyinno Biotechnology 20.10.2025

了解更多 »

Breakthrough Progress! FGFR3-Targeted Therapy Brings New Hope for Bladder Cancer Patients

Kyinno Biotechnology 17.10.2025

了解更多 »

MPSA-AB5000 Combined with CRISPR Gene-Edited Cell Models Provides a High-Specificity Screening Platform for Antibody Drug Development

Kyinno Biotechnology 13.10.2025

了解更多 »

Fluorescence Imaging Technology Supports JAK2 Target Research, JAK2 Inhibitor Treatment Effect “Visualization”!

Kyinno Biotechnology 09.10.2025

了解更多 »

Fluorescence Imaging Technology Enables JAK2 Target Research and “Visualization” of JAK2 Inhibitor Efficacy!

Kyinno Biotechnology 05.10.2025

了解更多 »

CRISPR Gene Editing Enables Precision Screening: Unlocking the Dual Value of “Off-Target Screening + Bystander Effect” with the MPSA-AB5000 Platform

Kyinno Biotechnology 22.09.2025

了解更多 »

PROTAC: A Sword Sharpened for 20 Years, Cracking the “Undruggable” Targets in Cancer!

Kyinno Biotechnology 19.09.2025

了解更多 »

Breakthrough in SSTR2-Targeted ADC

Kyinno Biotechnology 15.09.2025

了解更多 »